{
    "2020-12-23": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Bull",
                        "Bear",
                        "Qualcomm",
                        "AbbVie",
                        "Garmin"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "IMBRUVICA® (ibrutinib) U.S. Prescribing Information Updated to Include Long-Term Data for Waldenström's Macroglobulinemia (WM)",
                "features": {
                    "keywords": [
                        "IMBRUVICA",
                        "ibrutinib",
                        "Prescribing",
                        "Information",
                        "Long-Term",
                        "Data",
                        "Waldenström's",
                        "Macroglobulinemia"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "3 Stocks to Buy With Dividends Yielding More Than 4%",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Buy",
                        "Dividends",
                        "Yielding",
                        "More",
                        "Than",
                        "4%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Coronavirus Stimulus Checks: Top Stocks To Buy Now",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Stimulus",
                        "Checks",
                        "Top",
                        "Stocks",
                        "Buy",
                        "Now"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "economy",
                        "stimulus"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}